Activity ID
11940Expires
May 18, 2024Format Type
LiveCME Credit
1Fee
$0CME Provider: Clinical Care Options, LLC
Description of CME Course
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Schizophrenia
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
• Incorporate evidence-based recommendations to monitor patients receiving antipsychotics for adherence and AEs
• Identify the role of newer and emerging agents in addressing unmet needs in the current treatment of schizophrenia
• Analyze characteristics of emerging treatments for schizophrenia, including novel mechanisms of action, kinetics, efficacy, and AE profiles
Keywords
Schizophrenia
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military
